331 related articles for article (PubMed ID: 11301351)
1. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract][Full Text] [Related]
2. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
4. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R
Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
[TBL] [Abstract][Full Text] [Related]
5. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
Barrios C; Castresana JS; Ruiz J; Kreicbergs A
J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
[TBL] [Abstract][Full Text] [Related]
6. Activation of RAS family genes in urothelial carcinoma.
Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
[TBL] [Abstract][Full Text] [Related]
7. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
[TBL] [Abstract][Full Text] [Related]
8. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients.
Cuatrecasas M; Erill N; Musulen E; Costa I; Matias-Guiu X; Prat J
Cancer; 1998 Mar; 82(6):1088-95. PubMed ID: 9506354
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
10. Dedifferentiation of low grade chondrosarcomas.
McFarland GB; McKinley LM; Reed RJ
Clin Orthop Relat Res; 1977; (122):157-64. PubMed ID: 837602
[TBL] [Abstract][Full Text] [Related]
11. Optimization of restriction fragment length polymorphism and single strand conformation polymorphism analysis for the detection of point mutations of ras oncogenes in paraffin-embedded tissues.
Weise B; Ghebremedhin E; Zschunke F; Radzun HJ
Gen Diagn Pathol; 1996 Jun; 142(1):45-52. PubMed ID: 8793486
[TBL] [Abstract][Full Text] [Related]
12. [Poorly differentiated ("dedifferentiated") chondrosarcoma].
Petrovichev NN; Eremina LA; Khmelev LA; Kasumov NV
Vopr Onkol; 1984; 30(1):8-13. PubMed ID: 6695530
[TBL] [Abstract][Full Text] [Related]
13. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
Detorakis ET; Zafiropoulos A; Arvanitis DA; Spandidos DA
Eye (Lond); 2005 Feb; 19(2):210-4. PubMed ID: 15232598
[TBL] [Abstract][Full Text] [Related]
14. Rb-loss is associated with high malignancy in chondrosarcoma.
Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
[TBL] [Abstract][Full Text] [Related]
15. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas.
Bohle RM; Brettreich S; Repp R; Borkhardt A; Kosmehl H; Altmannsberger HM
Am J Pathol; 1996 Mar; 148(3):731-8. PubMed ID: 8774129
[TBL] [Abstract][Full Text] [Related]
16. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
Demunter A; Ahmadian MR; Libbrecht L; Stas M; Baens M; Scheffzek K; Degreef H; De Wolf-Peeters C; van Den Oord JJ
Cancer Res; 2001 Jun; 61(12):4916-22. PubMed ID: 11406571
[TBL] [Abstract][Full Text] [Related]
17. H-ras mutation is an additional event of sarcomatous transformation in aerodigestive spindle cell carcinoma.
Shiratsuchi H; Hirakawa N; Saito T; Oda Y; Yamamoto H; Tomita K; Yamamoto T; Tsuneyoshi M
Oncol Rep; 2004 Mar; 11(3):597-604. PubMed ID: 14767509
[TBL] [Abstract][Full Text] [Related]
18. [Clinico-morphological characteristics of bone chondrosarcomas].
Petrovichev NN; Eremina LA; Kasumov NV
Vopr Onkol; 1984; 30(4):14-20. PubMed ID: 6730402
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
20. [K-ras gene mutation in gallbladder carcinoma].
Roa JC; Roa I; de Aretxabala X; Melo A; Faría G; Tapia O
Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
